BACKGROUND: This study is to assess differences in periprocedural outcomes among diabetic and non-diabetic patients treated with percutaneous coronary intervention (PCI) and rotational atherectomy (RA). METHODS: Under assessment were 221,187 patients from the Polish Cardiovascular Intervention Society national registry (ORPKI) including all PCIs performed in Poland in 2015 and 2016. Data was extracted of 975 patients treated with RA - 336 (34.5%) diabetics and 639 (65.5%) non-diabetics. Periprocedural complications were defined as overall rate or particular complications such as deaths, no-reflows, perforations, dissections, cerebral strokes or bleedings.. Multivariate analysis was performed to assess predictors of periprocedural complications. RESULTS: The mean age was similar in diabetics and non-diabetics (70.9 ± 9.0 vs. 72.1 ± 9.9; p = 0.06). Diabetics were more often females (p < 0.01), with arterial hypertension (p < 0.01), kidney failure (p < 0.01) and prior myocardial infarction (p = 0.01). No significant differences were observed in overall or individual periprocedural complications and angiographic success was expressed as thrombolysis in myocardial infarction grade 3 flow after PCI. At baseline, de-novo lesions accounted for 96.5% in diabetics and 99% in non-diabetics (p < 0.01), while overall rate of restenosis was 3.5% and 1%, respectively (p < 0.01). Diabetes was an independent predictor of periprocedural complications in the overall group of patients treated with PCI (OR 1.11, 95% CI 1.04-1.194; p < 0.001). CONCLUSIONS: The negative impact of diabetes on the incidence of periprocedural complications and angiographic effectiveness in the group of patients treated with RA is mitigated in the comparison to the non-RA group.
BACKGROUND: This study is to assess differences in periprocedural outcomes among diabetic and non-diabeticpatients treated with percutaneous coronary intervention (PCI) and rotational atherectomy (RA). METHODS: Under assessment were 221,187 patients from the Polish Cardiovascular Intervention Society national registry (ORPKI) including all PCIs performed in Poland in 2015 and 2016. Data was extracted of 975 patients treated with RA - 336 (34.5%) diabetics and 639 (65.5%) non-diabetics. Periprocedural complications were defined as overall rate or particular complications such as deaths, no-reflows, perforations, dissections, cerebral strokes or bleedings.. Multivariate analysis was performed to assess predictors of periprocedural complications. RESULTS: The mean age was similar in diabetics and non-diabetics (70.9 ± 9.0 vs. 72.1 ± 9.9; p = 0.06). Diabetics were more often females (p < 0.01), with arterial hypertension (p < 0.01), kidney failure (p < 0.01) and prior myocardial infarction (p = 0.01). No significant differences were observed in overall or individual periprocedural complications and angiographic success was expressed as thrombolysis in myocardial infarction grade 3 flow after PCI. At baseline, de-novo lesions accounted for 96.5% in diabetics and 99% in non-diabetics (p < 0.01), while overall rate of restenosis was 3.5% and 1%, respectively (p < 0.01). Diabetes was an independent predictor of periprocedural complications in the overall group of patients treated with PCI (OR 1.11, 95% CI 1.04-1.194; p < 0.001). CONCLUSIONS: The negative impact of diabetes on the incidence of periprocedural complications and angiographic effectiveness in the group of patients treated with RA is mitigated in the comparison to the non-RA group.
Authors: K Kishi; Y Hiasa; T Ogata; M Murata; T Harada; J Yamashita; N Suzuki; H Miyamoto; T Takahashi; S Hosokawa; M Tanimoto; R Otani Journal: Am J Cardiol Date: 2001-04-01 Impact factor: 2.778
Authors: Philippe Généreux; Mahesh V Madhavan; Gary S Mintz; Akiko Maehara; Tullio Palmerini; Laura Lasalle; Ke Xu; Tom McAndrew; Ajay Kirtane; Alexandra J Lansky; Sorin J Brener; Roxana Mehran; Gregg W Stone Journal: J Am Coll Cardiol Date: 2014-02-19 Impact factor: 24.094
Authors: G N Levine; A K Jacobs; G P Keeler; P L Whitlow; L G Berdan; F Leya; E J Topol; R M Califf Journal: Am J Cardiol Date: 1997-03-15 Impact factor: 2.778
Authors: Rafał Januszek; Zbigniew Siudak; Artur Dziewierz; Tomasz Rakowski; Dariusz Dudek; Stanisław Bartuś Journal: Pol Arch Intern Med Date: 2017-11-07
Authors: Gennaro Giustino; Ioannis Mastoris; Usman Baber; Samantha Sartori; Gregg W Stone; Martin B Leon; Patrick W Serruys; Adnan Kastrati; Stephan Windecker; Marco Valgimigli; George D Dangas; Clemens Von Birgelen; Pieter C Smits; David Kandzari; Soren Galatius; William Wijns; P Gabriel Steg; Giulio G Stefanini; Melissa Aquino; Marie-Claude Morice; Edoardo Camenzind; Giora Weisz; Raban V Jeger; Takeshi Kimura; Ghada W Mikhail; Dipti Itchhaporia; Laxmi Mehta; Rebecca Ortega; Hyo-Soo Kim; Alaide Chieffo; Roxana Mehran Journal: JACC Cardiovasc Interv Date: 2016-09-26 Impact factor: 11.195
Authors: Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Ajay J Kirtane; Robert A Byrne; David O Williams; James Slater; Donald E Cutlip; Frederick Feit Journal: BMJ Date: 2012-08-10
Authors: Rafał Januszek; Zbigniew Siudak; Krzysztof Reczuch; Sławomir Dobrzycki; Maciej Lesiak; Jacek Legutko; Paweł Kleczyński; Łukasz Rzeszutko; Dariusz Dudek; Stanisław Bartuś Journal: Postepy Kardiol Interwencyjnej Date: 2019-01-18 Impact factor: 1.426
Authors: Rafał Januszek; Artur Dziewierz; Zbigniew Siudak; Tomasz Rakowski; Tomasz Kameczura; Tomasz Tokarek; Dariusz Dudek; Stanisław Bartuś Journal: Arch Med Sci Date: 2019-06-22 Impact factor: 3.318